Please click here if you wish to receive an e-mail notification regarding Alector press releases. Year None20242023202220212020201920182017 Feb 28, 2024 Alector to Participate in Upcoming Healthcare Conferences Feb 27, 2024 Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Feb 20, 2024 Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call Feb 08, 2024 Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease Feb 07, 2024 FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) Jan 19, 2024 Alector Announces Closing of Public Offering Jan 17, 2024 Alector Announces Pricing of Public Offering of Common Stock Jan 16, 2024 Alector Announces Proposed Public Offering of Common Stock